SXTP Insider Trading Activity and SEC Form 4 Filings
SXTP insider trading summary
Over the past 12 months, insiders at 60 Degrees Pharmaceuticals, Inc. (SXTP) reported 4 open-market purchases worth $30K by 1 insider and no sales on SEC Form 4. Net insider buying was $30K.
Latest SXTP insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Jun 12, 2026 | Geoffrey S Dow | President and CEO | Buy | $10K (7,350 @ $1.38) |
| Dec 15, 2025 | Geoffrey S Dow | President and CEO | Buy | $8K (9,670 @ $0.80) |
| Dec 11, 2025 | Geoffrey S Dow | President and CEO | Buy | $3K (3,613 @ $0.92) |
| Dec 10, 2025 | Geoffrey S Dow | President and CEO | Buy | $9K (9,350 @ $0.95) |
| Jun 3, 2025 | Cheryl Xu | Director | Buy | $6K (2,000 @ $2.90) |
| Jun 3, 2025 | Cheryl Xu | Director | Buy | $9K (3,000 @ $2.87) |
| Dec 16, 2024 | Cheryl Xu | Director | Buy | $3K (2,000 @ $1.45) |
| Dec 13, 2024 | Cheryl Xu | Director | Buy | $2K (1,500 @ $1.55) |
| Dec 13, 2024 | Cheryl Xu | Director | Buy | $2K (1,500 @ $1.60) |
| Dec 13, 2024 | Cheryl Xu | Director | Buy | $2K (1,500 @ $1.52) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.